| Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site T Tomasic, S Katsamakas, Z Hodnik, J Ilaš, M Brvar, T Solmajer, ... Journal of medicinal chemistry 58 (14), 5501-5521, 2015 | 124 | 2015 |
| Discovery of benzothiazole scaffold-based DNA gyrase B inhibitors M Gjorgjieva, T Tomasic, M Barancokova, S Katsamakas, J Ilas, ... Journal of medicinal chemistry 59 (19), 8941-8954, 2016 | 122 | 2016 |
| RGD-mediated delivery of small-molecule drugs S Katsamakas, T Chatzisideri, S Thysiadis, V Sarli Future medicinal chemistry 9 (6), 579-604, 2017 | 81 | 2017 |
| Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones M Voura, P Khan, S Thysiadis, S Katsamakas, A Queen, GM Hasan, S Ali, ... Scientific Reports 9 (1), 1676, 2019 | 52 | 2019 |
| Synthesis and biological evaluation of a Platinum (II)-c (RGDyK) conjugate for integrin-targeted photodynamic therapy T Chatzisideri, S Thysiadis, S Katsamakas, P Dalezis, I Sigala, ... European Journal of Medicinal Chemistry 141, 221-231, 2017 | 50 | 2017 |
| Advances of phenoxazines: Synthesis, reactivity and their medicinal applications S Katsamakas, A L Zografos, V Sarli Current medicinal chemistry 23 (26), 2972-2999, 2016 | 22 | 2016 |
| Synthesis, structure elucidation and biological evaluation of triple bridged dinuclear copper (II) complexes as anticancer and antioxidant/anti-inflammatory agents Z Boulsourani, S Katsamakas, GD Geromichalos, V Psycharis, ... Materials Science and Engineering: C 76, 1026-1040, 2017 | 21 | 2017 |
| Synthesis and evaluation of gallocyanine dyes as potential agents for the treatment of Alzheimer's disease and related neurodegenerative tauopathies S Mpousis, S Thysiadis, N Avramidis, S Katsamakas, S Efthimiopoulos, ... European Journal of Medicinal Chemistry 108, 28-38, 2016 | 21 | 2016 |
| Design and synthesis of gallocyanine inhibitors of DKK1/LRP6 interactions for treatment of Alzheimer’s disease S Thysiadis, S Katsamakas, S Mpousis, N Avramidis, S Efthimiopoulos, ... Bioorganic Chemistry 80, 230-244, 2018 | 17 | 2018 |
| Novel c (RGDyK)-based conjugates of POPAM and 5-fluorouracil for integrin-targeted cancer therapy S Thysiadis, S Katsamakas, P Dalezis, T Chatzisideri, D Trafalis, V Sarli Future medicinal chemistry 9 (18), 2181-2196, 2017 | 17 | 2017 |
| Interaction of Fe (III) with herbicide-carboxylato ligands–Di-, tri-and tetra-nuclear compounds: Structure and magnetic behavior C Dendrinou-Samara, S Katsamakas, C Raptopoulou, A Terzis, ... Polyhedron 26 (4), 763-772, 2007 | 15 | 2007 |
| Mononuclear copper (II) complexes with 2-thiophene carboxylate and NN donors; DNA interaction, antioxidant/anti-inflammatory and antitumor activity Z Boulsourani, GD Geromichalos, S Katsamakas, V Psycharis, ... Materials Science and Engineering: C 94, 493-508, 2019 | 13 | 2019 |
| Boronic acid group: A cumbersome false negative case in the process of drug design S Katsamakas, AG Papadopoulos, D Hadjipavlou-Litina Molecules 21 (9), 1185, 2016 | 13 | 2016 |
| Considering autotaxin inhibitors in terms of 2D-QSAR and 3D-mapping-review and evaluation S Katsamakas, E Bermperoglou, D Hadjipavlou-Litina Current medicinal chemistry 22 (12), 1428-1461, 2015 | 12 | 2015 |
| Examining barbiturate scaffold for the synthesis of new agents with biological interest S Katsamakas, AG Papadopoulos, MG Kouskoura, CK Markopoulou, ... Future Medicinal Chemistry 11 (16), 2063-2079, 2019 | 11 | 2019 |
| α-Amination and the 5-exo-trig cyclization reaction of sulfur-containing Schiff bases with N-phenyltriazolinedione and their anti-lipid peroxidation activity E Pelit, K Oikonomou, M Gul, D Georgiou, S Szafert, S Katsamakas, ... Comptes Rendus Chimie 20 (4), 424-434, 2017 | 8 | 2017 |
| Sulfanyl 5H-dihydropyrrole derivatives via 1, 3-dipolar cycloaddition, their further chemical manipulation and antioxidant activity. K Oikonomou, D Georgiou, S Katsamakas, D Hadjipavlou-Litina, ... ARKIVOC: Online Journal of Organic Chemistry 2015, 2015 | 8 | 2015 |
| Discovery of novel phenoxazinone derivatives as DKK1/LRP6 interaction inhibitors: Synthesis, biological evaluation and structure–activity relationships S Thysiadis, S Mpousis, N Avramidis, S Katsamakas, A Balomenos, ... Bioorganic & Medicinal Chemistry 24 (5), 1014-1022, 2016 | 7 | 2016 |
| Targeting on poly (ADP‐ribose) polymerase activity with DNA‐damaging hybrid lactam‐steroid alkylators in wild‐type and BRCA1‐mutated ovarian cancer cells DT Trafalis, A Polonifi, P Dalezis, N Nikoleousakos, S Katsamakas, V Sarli Chemical Biology & Drug Design 90 (5), 854-866, 2017 | 6 | 2017 |
| Computational design of multitarget drugs against Alzheimer’s disease S Katsamakas, D Hadjipavlou-Litina Multi-Target Drug Design Using Chem-Bioinformatic Approaches, 203-253, 2019 | 4 | 2019 |
